Business and Finance

The 7th Annual Model N survey shows that industry is struggling with the growing complexity of contracts and pricing for managed care and government programs

Acquisition boosts Medco’s ability to develop evidence-based medicine

Deloitte survey finds life sciences companies are consolidating some functions, whether in-house or outsourced

By running Commercial Operations like a stand-alone business, executives can sharpen their focus on strategy, tactics and overall performance

Examining off-label use of highly prescribed drugs reveals factors that differ from the usual criticism of such usage

Generics are now 75% of dispensed prescriptions, with generics up 5.9% in 2009 and branded products down 7.6%

‘Revenue Management’ Comes to the Rescue of Pharma’s Complex Pricing Environment

Investment funds have developed an interest in trading capital for royalties on drug commercializations

The growth of healthcare business is attracting many new players to the pharmaceutical arena, challenging pharma’s relationships with patients

Big Pharma is not yet deeply enough invested in faster-growing markets outside the developed economies

Shared-risk or ‘pay for performance’ agreements between drugmakers and payers can represent uncertain rewards for both parties. Use strategic planning before entering into them

A review of 84 branded pharmaceutical products with changed ownership as of 2005 shows that many of them can continue to sell, often with much higher prices By Albert I. Wertheimer, PhD, MBA, Temple University, and Ellen F. Loh, BS, MBA, University of Maryland, Baltimore

Survey shows close interplay between manufacturers and their trading partners for supplemental services

Annual survey rank public companies by environmental, social criteria

Industry woes go beyond current global economic downturn

Annual compilation tracks evolution of wholesaler services, adoption of new technologies

With sales of human pharmaceuticals languishing, several factors are focusing increased attention on animal health products, once a little-noticed industry niche market

Program seeks to improve the economics of care for low-income families; more sites to come

Specific, technology-based anticounterfeiting measures are a tactical response to a strategic problem. Holistic prevention strategies are needed

At 28% pharmaceutical sales, chain pharmacy still represents the single largest channel for delivering prescriptions to patients

Coming off a record-setting year, ABC stresses growth in generics, and services revolving around specialty pharmaceuticals

Effective integration of a company’s contract strategy with operations can have a big impact on financial performance

While drug spending by clients averaged 3.3% last year, higher spending growth is predicted for the next three years

US market will enter negative growth this year, says IMS Health

Specialty manufacturers have a range of options to consider in how to go to market

Better use of available data can add rigor to analyzing managed-markets contracts, thereby allocating rebates / discounts more effectively

US total reaches $291.5 billion; dispensed prescriptions up 0.9%